Toshitaka Yuza

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis

T. Ganz, Y. Higashimoto, N. Tomosugi, 2020, Clinical kidney journal.

Differential Impacts of Intravenous Iron Administration and Iron-Containing Phosphate Binders on Serum Intact Fibroblast Growth Factor 23 Levels

N. Tomosugi, T. Shibata, T. Michihata, 2019, Blood Purification.

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis

Toshinori Yamamoto, N. Tomosugi, T. Shibata, 2016, PloS one.

Effects of Long‐Term Erythropoiesis‐Stimulating Agents on Iron Metabolism in Patients on Hemodialysis

Toshinori Yamamoto, N. Tomosugi, T. Shibata, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.